Showing results (21-30 of 118) with videos related to

Sort By:
Pageof 12
Hormones & Cancer|July 16, 2011
Estrogen receptor alpha phosphorylated at tyrosine 537 is associated with poor clinical outcome in breast cancer patients treated with tamoxifenGeorgios P Skliris, Zoann Nugent, Peter H Watson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 10, 2008
Influence of evolution in tumor biobanking on the interpretation of translational researchRebecca O Barnes, Michelle Parisien, Leigh C Murphy, et al.
International Journal of Cancer|September 24, 2004
HLA-DRB alleles are differentially expressed by tumor cells in breast carcinomaSharon A Oldford, J Desmond Robb, Peter H Watson, et al.
Biopreservation and Biobanking|May 22, 2014
Biospecimen use correlates with emerging techniques in cancer research: impact on planning future biobanksAlexandra Cole, Stefanie Cheah, Simon Dee, et al.
Biopreservation and Biobanking|April 26, 2024
An Approach to Evaluate the Costs and Outputs of Academic BiobanksAmanda Rush, , Daniel R Catchpoole, et al.
The Journal of Steroid Biochemistry and Molecular Biology|February 5, 2008
Estrogen receptor alpha negative breast cancer patients: estrogen receptor beta as a therapeutic targetGeorge P Skliris, Etienne Leygue, Peter H Watson, et al.
Oncotarget|April 9, 2016
CD74 and intratumoral immune response in breast cancerZhi-Qiang Wang, Katy Milne, John R Webb, et al.
BMC Dermatology|February 26, 2003
Psoriasin (S100A7) expression is altered during skin tumorigenesisSalem Alowami, Gefei Qing, Ethan Emberley, et al.
Endocrine-Related Cancer|November 19, 2014
Intratumoural inflammation and endocrine resistance in breast cancerJill I Murray, Nathan R West, Leigh C Murphy, et al.
Experimental Cell Research|June 15, 2007
S100A7 (psoriasin) influences immune response genes in human breast cancerSoma Mandal, Linda Curtis, Molly Pind, et al.
Pageof 12